pH-Responsive Co-Assembled Peptide Hydrogel to Inhibit Drug-Resistant Bacterial Infection and Promote Wound Healing
Source abstract
Abstract
Drug-resistant bacterial infection and biofilm formation are the key inhibitors of wound healing, and new strategies are urgently needed to address these issues. In this study, we designed a pH-responsive co-assembled peptide hydrogel to inhibit Methicillin-resistant Staphylococcus aureus (MRSA) infection and promote wound healing. We synthesized a cationic short peptide (Nap-FFKKK) and a co-assembled hydrogel with curcumin at pH ∼ 7.8. The loaded curcumin was continuously released in a weak acid environment (pH ∼ 5.5). The lysine-rich cationic peptide inhibited biofilm formation in MRSA via electrostatic interaction with the negatively charged bacterial cell surface and, thus, provided a reinforcing antibacterial effect with curcumin. In vitro antibacterial experiments showed that the co-assembled system considerably reduced the minimum inhibitory concentration of curcumin against MRSA by 10-fold and promoted wound healing in a mouse model of MRSA-infected wounds. This study provides a simple and promising strategy to treat drug-resistant bacterial infections in wounds.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Supramolecular Self-Assembly in Materials · Antimicrobial Peptides and Activities · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
College of Chemistry & Pharmacy, Shaanxi Key Laboratory of Natural Products & Chemical Biology, Northwest A&F University, 22 Xinong Road, Yangling, Xianyang, Shaanxi 712100, P. R. China
Henan Eye Hospital, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, Zhengzhou 450003, P. R. China
Funding
National Natural Science Foundation of China · Henan Provincial Key project of Medical Science and Technology Program · Henan Provincial Medical Science and Technology Program
References (53)
Show source-provided references
1. 10.3390/ijms2406577710.3390/ijms24065777 ↗
2. 10.3390/medicina5809125710.3390/medicina58091257 ↗
3. 10.1016/j.annemergmed.2004.10.01110.1016/j.annemergmed.2004.10.011 ↗
4. 10.1111/nyas.1392610.1111/nyas.13926 ↗
5. 10.1002/adfm.20210665610.1002/adfm.202106656 ↗
6. 10.3390/pharmaceutics1602015510.3390/pharmaceutics16020155 ↗
7. 10.1002/advs.20210484310.1002/advs.202104843 ↗
8. 10.1093/nsr/nwae04410.1093/nsr/nwae044 ↗
9. 10.1021/acsnano.0c0385510.1021/acsnano.0c03855 ↗
10. 10.1002/pat.592910.1002/pat.5929 ↗
11. 10.1002/adhm.20210180810.1002/adhm.202101808 ↗
12. 10.1016/j.bioactmat.2022.03.03310.1016/j.bioactmat.2022.03.033 ↗
13. 10.1002/adma.20157014910.1002/adma.201570149 ↗
14. 10.1016/j.colsurfb.2023.11342410.1016/j.colsurfb.2023.113424 ↗
15. 10.1002/adfm.20230393010.1002/adfm.202303930 ↗
16. 10.1016/j.actbio.2013.08.01310.1016/j.actbio.2013.08.013 ↗
17. 10.1016/j.chempr.2018.05.01610.1016/j.chempr.2018.05.016 ↗
18. 10.1002/adfm.20230572610.1002/adfm.202305726 ↗
19. 10.1016/j.chempr.2018.07.00210.1016/j.chempr.2018.07.002 ↗
20. 10.1021/acsnano.0c0568110.1021/acsnano.0c05681 ↗
21. 10.3390/polym1505116010.3390/polym15051160 ↗
22. 10.1016/j.bioactmat.2021.09.02910.1016/j.bioactmat.2021.09.029 ↗
23. 10.1039/C6CS00176A10.1039/C6CS00176A ↗
24. 10.1002/smll.20190730910.1002/smll.201907309 ↗
25. 10.1016/j.addr.2016.08.00610.1016/j.addr.2016.08.006 ↗
26. 10.1016/j.ccr.2023.21560010.1016/j.ccr.2023.215600 ↗
27. 10.1021/acs.biomac.3c0101810.1021/acs.biomac.3c01018 ↗
28. 10.1021/acsanm.1c0395910.1021/acsanm.1c03959 ↗
29. 10.1016/j.biomaterials.2020.12053610.1016/j.biomaterials.2020.120536 ↗
30. 10.1021/acsnano.5b0656710.1021/acsnano.5b06567 ↗
31. 10.1016/j.chempr.2016.07.00310.1016/j.chempr.2016.07.003 ↗
32. 10.1002/adfm.20210917310.1002/adfm.202109173 ↗
33. 10.1016/j.foodchem.2023.13627210.1016/j.foodchem.2023.136272 ↗
34. 10.1016/j.cclet.2023.10820910.1016/j.cclet.2023.108209 ↗
35. 10.1002/adfm.20210670510.1002/adfm.202106705 ↗
36. 10.1016/j.jamda.2016.12.07110.1016/j.jamda.2016.12.071 ↗
37. 10.1016/j.ijpharm.2016.12.05710.1016/j.ijpharm.2016.12.057 ↗
38. 10.1016/j.carbpol.2023.12085210.1016/j.carbpol.2023.120852 ↗
39. 10.1007/s13277-016-5183-y10.1007/s13277-016-5183-y ↗
40. 10.1002/biof.153310.1002/biof.1533 ↗
41. 10.1016/j.ijbiomac.2023.12615310.1016/j.ijbiomac.2023.126153 ↗
42. 10.1002/jsfa.1137210.1002/jsfa.11372 ↗
43. 10.1021/acsnano.9b0560810.1021/acsnano.9b05608 ↗
44. 10.2147/IJN.S5587510.2147/IJN.S55875 ↗
45. 10.1016/j.cej.2021.13097910.1016/j.cej.2021.130979 ↗
46. 10.1016/j.jconrel.2018.12.01410.1016/j.jconrel.2018.12.014 ↗
47. 10.1002/anie.20191178210.1002/anie.201911782 ↗
48. 10.1016/j.chempr.2023.05.00910.1016/j.chempr.2023.05.009 ↗
49. 10.1038/nmat377610.1038/nmat3776 ↗
50. 10.1016/j.bioactmat.2022.02.01810.1016/j.bioactmat.2022.02.018 ↗
51. 10.1172/jci14953810.1172/jci149538 ↗
52. 10.1021/acsomega.2c0701810.1021/acsomega.2c07018 ↗
53. 10.1002/adma.20220052110.1002/adma.202200521 ↗